secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alkermes plc. (ALKS)
CIK:        0001520262
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0000950170-24-027585
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alkermes appoints Nancy S. Lurker to Board of Directors, increasing size to 11
------------------------------------------------------------------------------

- Board expanded to 11 directors; Nancy S. Lurker elected effective March 5, 2024, term expiring at 2024 annual meeting.
- Lurker brings decades of pharmaceutical/biotech leadership and commercial expertise; CEO highlights alignment with growth strategy.
- She will receive standard new director equity grant and annual cash retainer; equity grants in April 2024 subject to re-election forfeiture.
- Lurker not a party to any related-party transactions since Jan 1, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1520262/000095017024027585/0000950170-24-027585-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1520262/000095017024027585/alks-20240305.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-027585

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer